Sternal Closure Systems Market Insights 2032: Drivers Behind Innovation in Closure Systems
Sternal Closure Systems Market Insights 2032: Drivers Behind Innovation in Closure Systems
The Sternal Closure Systems Market is steadily growing as the number of cardiac and thoracic surgeries—such as median sternotomy—increases worldwide. These systems, including rigid fixation plates, screws, cables, and bone cement, are designed to stabilize the breastbone after open-chest surgery, promoting healing and reducing complications. Titanium dominates the material segment due to its strength, biocompatibility, and MRI compatibility, while emerging polymers like PEEK are gaining traction for their lightweight and radiolucent properties. North America leads the market, supported by high surgical volume and early adoption of advanced fixation technologies, while Asia-Pacific is delivering the fastest growth driven by expanding healthcare infrastructure and rising demand for cardiac procedures. Market expansion is supported by technological innovation, patient-centric surgical protocols, and greater awareness among clinicians about the benefits of rigid fixation over traditional wire closure.
According to Fortune Business Insights, the global sternal closure systems market size was valued at USD 1.98 billion in 2024. The market is projected to grow from USD 2.10 billion in 2025 to USD 3.13 billion by 2032, exhibiting a CAGR of 5.9% during the 2025–2032 period. North America dominated the sternal closure systems market with a market share of 45.23% in 2024.
Johnson and Johnson Services Inc. (U.S)
Zimmer Biomet (U.S)
KLS Martin Group (Germany)
B Braun Medical (Germany)
Stryker (U.S)
Jace Medical, LLC (U.S)
Kinamed Incorporated (U.S)
Idear S.R.L (Argentina)
Acute Innovations (U.S)
Other Predominant Players
In June 2021, Able Medical Devices rolled out the Valkyrie Thoracic Fixation System—the first single‑use, radiolucent plating system specifically designed to span osteotomies and secure sternums after open‑heart surgery. This move signals a shift toward disposable, image‑friendly stabilization technologies.
Rising Cardiovascular Disease Burden: Around 18 million Americans above age two live with coronary artery disease, fueling demand for procedures requiring sternal closure.
Increasing Open‑Heart Surgeries: An average of 500,000 open‑heart surgeries are performed annually in the U.S., directly boosting demand for sternal closure systems.
Post‑COVID Rebound: Elective cardiac procedures dropped 27.8% in 2020 but are recovering, driving renewed uptake of advanced closure devices .
Technological Innovation & M&A Activity: Innovations like radiolucent, disposable plates and strategic buyouts—such as Zimmer Biomet acquiring A&E Medical—are expanding product capabilities.
Shift Toward Minimally Invasive Techniques: As minimally invasive cardiac surgeries rise—200,000 annually in the U.S.—proponents debate the necessity of sternal closure devices.
The Fortune Business Insights report offers a thorough industry breakdown:
Product type: closure devices vs. bone cement
Procedure type: median, bilateral, or hemisternotomy
Material type: stainless steel, titanium, and PEEK
Regional insights across North America, Europe, Asia‑Pacific, Latin America, and MEA
It additionally covers market sizing, historic trends, post‑COVID impact, and competitive calculations.
The market demonstrates moderate competitiveness with key players such as Johnson & Johnson (via DePuy Synthes), Zimmer Biomet, and KLS Martin leading the landscape. Growth strategies include product innovation (e.g., disposables, image‑transparent plates), FDA approvals (e.g., A&E Medical's Sternal Cable in 2020), and consolidation activities like Zimmer’s acquisition.
Closure Devices: Predominant segment in 2024, driven by new technologies and preference over bone cement.
Bone Cement: Smaller share; remains relevant in markets like Latin America, Middle East, and Africa.
Titanium: Leading material due to biocompatibility, corrosion resistance, and innovation focus.
PEEK: Fast‑growing segment; new research investment driving adoption.
Stainless Steel: Still used, but slower growth due to rise of advanced materials.
Median Sternotomy: Held majority share in 2024, supported by geriatric surgery rates and lower post‑op infection.
Bilateral Sternotomy & Hemisternotomy: Smaller niches with uptake, depending on surgical indications.
North America: Dominating region with USD 895.7 million in 2024 revenue—attributed to high cardiovascular disease prevalence and advanced device adoption.
Europe: Growth fueled by public health investment, CE‑marked device launches, joint implant use, and rising day‑care cardiac procedures.
Asia‑Pacific: Fastest expansion driven by large patient base, growing infrastructure, aging demographics (e.g., Japan’s elderly rising from 28% to 38% by 2050), and increased elective surgery rates.
Latin America & MEA: Emerging growth as orthopaedic device adoption and health services improve.
Explore the full research report with detailed insights and TOC:https://www.fortunebusinessinsights.com/sternal-closure-systems-market-102039
The market's future is bright—positioned for innovation via radiolucent, disposable plating systems; advanced materials like PEEK; and ongoing consolidation among major medical device firms. While minimally invasive surgery could dampen some demand, robust cardiovascular disease prevalence and surgical volume growth will sustain steady market expansion through 2032.
In summary, the sternal closure systems market is on track to reach USD 3.13 billion by 2032, propelled by a growing cardiovascular disease burden, technological breakthroughs, and recovery in elective procedures. Titanium plates and PEEK innovations, along with median sternotomy’s dominance, reinforce a diversified and resilient growth outlook. Market consolidation and strategic product launches are positioning industry leaders to capitalise on this trend, shaping a future where reliable, advanced sternal fixation becomes the clinical standard.
About Us:
Fortune Business Insights provides expert corporate analysis and accurate data, enabling businesses of all sizes to make timely decisions. We offer customized solutions tailored to each client’s needs, helping them address unique challenges. Our goal is to empower clients with holistic market intelligence and offer granular insights into the market they operate in.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA: +1 833 909 2966 (Toll-Free),
United Kingdom: +44 808 502 0280 (Toll-Free),
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com